Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,018.00
Bid: 12,018.00
Ask: 12,022.00
Change: -6.00 (-0.05%)
Spread: 4.00 (0.033%)
Open: 11,950.00
High: 12,066.00
Low: 11,944.00
Prev. Close: 12,024.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stocks slip as investors digest earnings, Barclays rises

Wed, 30th Jul 2014 08:26

- Barclays rises as investors digest wave of corporate earnings- Russian sanctions, Gaza and Argentina in focus- US economic data, Fed decision due out later ontechMARK 2,785.48 +0.12%FTSE 100 6,797.66 -0.15%FTSE 250 15,671.08 -0.10%UK markets opened slightly lower on Wednesday as investors digested a wave of corporate earnings and cautiously awaited economic data and a policy decision Stateside later on.Meanwhile, traders were still watching developments in the Ukraine crisis after US and EU leaders announced a fresh round of sanctions on Russia yesterday. Relentless fighting in Gaza and a potential debt default in Argentina were also likely to be weighing on risk appetite.The FTSE 100 was trading down 0.2% at 6,798 in early trading as strong gains from Barclays, Travis Perkins and AstraZeneca were offset by falls from Antofagasta, ITV and Tullow Oil.After a relatively quiet start to the week macro-wise, things will pick up today with a flurry of economic indicators due out during the morning session, including Eurozone confidence data and Germany inflation.However, the focus is likely to be on the US later on with the closely-watched ADP employment report and second-quarter gross domestic product (GDP) estimates due out before the opening bell on Wall Street, and the Federal Reserve's policy decision scheduled for this evening.Angus Campbell, Senior Analyst at FxPro, said that the GDP figures are "like to move the market most - this is because tonight's [Fed meeting] does not include a press conference and so there's unlikely to be any changes to what we saw or heard last month".Barclays leads banks higherBarclays was a high riser this morning as it reported a less-than-expected 12% fall in total income adjusted for insurance claims for the first half to £13.32bn, driven by reductions at its investment and African banking units. The consensus estimate had been for a drop to £13.23bn.Domestic banking peers RBS and Lloyds were also on the rise.Housebuilder Travis Perkins also impressed as it reported double-digit growth across the board in the first half, with like-for-like revenues up 10.2% and profits up 16%. The company said it expects "continued solid growth" for the rest of the year.Astrazeneca was in demand after it struck a deal with drug developer Almirall for the rights to the Spanish group's respiratory franchise. The initial consideration is $875m,Chile-focused mining group Antofagasta underwhelmed as it maintained its production guidance for 2014 after a sequential increase in output in the second quarter, while net cash costs were broadly flat.Shares of broadcaster ITV were in negative territory with the stock retreating after its recent strong run. Nevertheless, the company managed to beat expectations with its first-half results this morning with pre-tax profits up 16%.Also lower was Tullow Oil as it dropped into the red in the first half of 2014, after exploration write-offs more than doubled. Tullow reported a loss before tax of $29m in the first six months of the year, compared with a profit of $486m in the first half of 2013.FTSE 100 - RisersBarclays (BARC) 226.35p +3.31%Travis Perkins (TPK) 1,679.00p +2.07%Severn Trent (SVT) 1,955.00p +0.93%AstraZeneca (AZN) 4,353.00p +0.71%Royal Bank of Scotland Group (RBS) 356.20p +0.62%Capita (CPI) 1,222.00p +0.58%Carnival (CCL) 2,139.00p +0.56%BT Group (BT.A) 389.00p +0.52%Reckitt Benckiser Group (RB.) 5,245.00p +0.48%Vodafone Group (VOD) 203.70p +0.39%FTSE 100 - FallersAntofagasta (ANTO) 838.00p -1.99%Sainsbury (J) (SBRY) 318.40p -1.52%GKN (GKN) 360.60p -1.48%CRH (CRH) 1,442.00p -1.44%Compass Group (CPG) 994.00p -1.39%WPP (WPP) 1,196.00p -0.99%Rio Tinto (RIO) 3,441.00p -0.98%TUI Travel (TT.) 364.50p -0.84%Morrison (Wm) Supermarkets (MRW) 173.10p -0.80%Sports Direct International (SPD) 687.50p -0.79%FTSE 250 - RisersPets at Home Group (PETS) 182.30p +7.24%Riverstone Energy Limited (RSE) 925.00p +2.21%IP Group (IPO) 195.90p +2.14%Dignity (DTY) 1,408.00p +1.88%Perform Group (PER) 211.00p +1.78%National Express Group (NEX) 261.00p +1.68%Diploma (DPLM) 635.50p +1.68%Fisher (James) & Sons (FSJ) 1,337.00p +1.60%Taylor Wimpey (TW.) 116.40p +1.57%BTG (BTG) 616.00p +1.48%FTSE 250 - FallersVedanta Resources (VED) 1,057.00p -3.03%Jupiter Fund Management (JUP) 406.70p -2.02%Investec (INVP) 525.50p -1.78%Pace (PIC) 355.90p -1.66%Betfair Group (BET) 1,026.00p -1.63%Beazley (BEZ) 254.30p -1.59%Rotork (ROR) 2,767.00p -1.53%Spectris (SXS) 1,931.00p -1.48%International Personal Finance (IPF) 577.50p -1.45%Fenner (FENR) 337.60p -1.43%BC
More News
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.